Our Pricing

Wegovy Injection UK Private Prescription Online

Published on: June 03, 2026

Seeking a wegovy injection uk private prescription with transparent pricing and expert clinical support? Cured Pharmacy offers genuine UK-licensed Wegovy from £79.00, with free online consultations completed in under 3 minutes by our UK-registered prescribers. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets MHRA standards for safety and efficacy.

How Wegovy Semaglutide Injection Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics the natural GLP-1 hormone, which regulates appetite by acting on brain regions that control hunger and food intake.

In the landmark STEP 1 trial, participants using Wegovy achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. The once-weekly subcutaneous injection offers consistent therapeutic levels throughout the week, reducing the burden of daily medication and improving adherence to treatment programmes.

Clinical trials demonstrated that semaglutide not only reduces body weight but may also improve cardiovascular risk markers, including blood pressure and lipid profiles [2]. The medication works by slowing gastric emptying, increasing feelings of fullness after meals, and reducing overall caloric intake without requiring extreme dietary restriction.

Wegovy Injection UK Private Prescription Process at Cured Pharmacy

Obtaining your Wegovy injection UK private prescription through Cured Pharmacy is straightforward and fully compliant with UK prescribing regulations. Our online clinical assessment takes under 3 minutes to complete and covers your medical history, current medications, weight management goals, and any contraindications that may affect suitability.

Once submitted, a UK-registered prescriber reviews your assessment within hours. If Wegovy is clinically appropriate for you, your prescription is issued electronically and sent directly to our GPhC-registered dispensary (Registration Number 9012511). We dispense only genuine UK-licensed medicines sourced through regulated pharmaceutical wholesalers.

Your Wegovy injection arrives in 100% discreet packaging with no external branding, typically within 1-2 working days via tracked courier. Each pen comes with full patient information leaflets, dosing instructions, and access to our clinical support team should you have questions during your treatment journey.

Who Can Get a Wegovy Private Prescription?

Wegovy is licensed for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related health conditions such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. Your prescriber will assess whether Wegovy is suitable based on your individual medical profile, including any history of thyroid disorders, pancreatitis, or diabetic retinopathy.

Wegovy is not suitable during pregnancy or breastfeeding, and patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use semaglutide [3]. Your online consultation ensures all contraindications are identified before any prescription is issued.

Wegovy Dosing Schedule and Treatment Timeline

Wegovy follows a gradual dose escalation protocol designed to minimise gastrointestinal side effects while optimising weight loss outcomes. Treatment begins with 0.25 mg once weekly for four weeks, then increases to 0.5 mg, 1 mg, 1.7 mg, and finally the maintenance dose of 2.4 mg over a 16-week titration period [3].

This stepwise approach allows your body to adjust to semaglutide's effects on gastric emptying and appetite regulation. Most patients report noticeable appetite suppression within the first 2-4 weeks, with measurable weight loss typically observed by week 8-12 of treatment [1].

Clinical guidelines recommend continuing Wegovy only if you achieve at least 5% body weight reduction after 12 weeks at the maintenance dose [3]. Your prescriber will monitor your progress through follow-up consultations to ensure treatment remains effective and appropriate for your weight management goals.

Injecting Wegovy: Technique and Best Practices

Wegovy is administered subcutaneously into the abdomen, thigh, or upper arm using the pre-filled FlexTouch pen. Rotate injection sites each week to reduce the risk of lipodystrophy and maintain consistent absorption. The injection can be given at any time of day, with or without meals, but maintaining a consistent weekly schedule optimises therapeutic levels.

Each pen is single-use and should be disposed of in a sharps container after administration. Store unused pens in the refrigerator between 2°C and 8°C, and never freeze. Once in use, Wegovy pens can be stored at room temperature (below 30°C) for up to 28 days if needed for travel or convenience.

Wegovy Side Effects and How to Manage Them

The most common side effects of Wegovy are gastrointestinal and include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [3]. These symptoms are typically mild to moderate and diminish as your body adjusts to each dose level during the titration phase.

To minimise nausea, eat smaller, more frequent meals, avoid high-fat or spicy foods, and stay well-hydrated throughout the day. If gastrointestinal symptoms persist or become severe, your prescriber may recommend slowing the dose escalation or temporarily maintaining your current dose for an additional week before increasing.

Serious but rare side effects include pancreatitis (severe abdominal pain radiating to the back), gallbladder problems, and hypoglycaemia in patients taking other glucose-lowering medications [3]. Seek immediate medical attention if you experience persistent severe abdominal pain, visual changes, or signs of an allergic reaction such as swelling of the face or difficulty breathing.

Wegovy vs Saxenda: Comparing GLP-1 Weight Loss Injections

Both Wegovy and Saxenda are GLP-1 receptor agonists licensed in the UK for weight management, but they differ significantly in dosing frequency, efficacy, and patient experience. Wegovy contains semaglutide and is administered once weekly, while Saxenda contains liraglutide and requires daily subcutaneous injections.

Clinical trial data shows Wegovy produces greater average weight loss than Saxenda. In head-to-head comparisons, semaglutide 2.4 mg weekly resulted in superior weight reduction compared to liraglutide 3 mg daily [2]. The convenience of once-weekly dosing with Wegovy also improves treatment adherence, particularly for patients with busy schedules or needle anxiety.

Your prescriber will consider factors including your weight loss goals, previous medication experience, tolerance for injection frequency, and cost when recommending between Wegovy and Saxenda. Both medications require commitment to lifestyle modifications including reduced caloric intake and increased physical activity for optimal results.

Which GLP-1 Injection Is Right for You?

Patients who prefer less frequent injections and seek maximum weight loss efficacy typically favour Wegovy, while those who have previously used daily GLP-1 medications or prefer gradual dose adjustments may find Saxenda more suitable. Both medications are effective when used as part of a comprehensive weight management programme.

At Cured Pharmacy, our UK prescribers assess your individual clinical profile during your free online consultation to determine the most appropriate GLP-1 treatment. Pricing, efficacy data, and your personal preferences all factor into the clinical decision-making process.

Wegovy Injection UK Cost and Pricing Transparency

At Cured Pharmacy, Wegovy injection UK private prescription costs start from £79.00, with transparent upfront pricing displayed before you begin your clinical assessment. Unlike many online providers, we show exact costs per dose strength, so you know precisely what you'll pay before completing your consultation.

The final cost depends on your prescribed dose and treatment duration. Most patients progress through the titration schedule and remain on the 2.4 mg maintenance dose for ongoing weight management. We offer the lowest prices guaranteed across UK-registered online pharmacies, with no hidden consultation fees or subscription charges.

All Wegovy prescriptions include free delivery via tracked courier, clinical support from our UK-registered pharmacy team, and access to follow-up consultations to monitor your progress. We accept all major payment methods and ensure complete discretion in packaging and billing descriptors.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Sørrig, R. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency (MHRA). Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to lifestyle modifications including diet and exercise.